1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Nerve Repair & Regeneration Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Nerve Repair & Regeneration Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Nerve Repair & Regeneration Market Regional Analysis
6.2 Europe Nerve Repair & Regeneration Market Revenue 2020-2028 (US$ Million)
6.3 Europe Nerve Repair & Regeneration Market Forecast Analysis
7. Europe Nerve Repair & Regeneration Market Analysis – by Product
7.1 Neurostimulation & Neuromodulation Devices
- 7.1.1 Overview
- 7.1.2 Neurostimulation & Neuromodulation Devices: Europe Nerve Repair & Regeneration Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Biomaterials
- 7.2.1 Overview
- 7.2.2 Biomaterials: Europe Nerve Repair & Regeneration Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe Nerve Repair & Regeneration Market Analysis – by Application
8.1 Neurostimulation & Neuromodulation Applications
- 8.1.1 Overview
- 8.1.2 Neurostimulation & Neuromodulation Applications: Europe Nerve Repair & Regeneration Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Nerve Repair & Regeneration Applications
- 8.2.1 Overview
- 8.2.2 Nerve Repair & Regeneration Applications: Europe Nerve Repair & Regeneration Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe Nerve Repair & Regeneration Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Nerve Repair & Regeneration Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 Europe Nerve Repair & Regeneration Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.1.2 UK: Europe Nerve Repair & Regeneration Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.2.2 Germany: Europe Nerve Repair & Regeneration Market Breakdown, by Application
- 9.2.1.3 France:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.3.2 France: Europe Nerve Repair & Regeneration Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.4.2 Russia: Europe Nerve Repair & Regeneration Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.5.2 Italy: Europe Nerve Repair & Regeneration Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Nerve Repair & Regeneration Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Nerve Repair & Regeneration Market Breakdown, by Product
- 9.2.1.6.2 Rest of Europe: Europe Nerve Repair & Regeneration Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Axogen Corporation
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Boston Scientific Corporation
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Integra LifeSciences
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medtronic
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Abbott Laboratories
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Stryker Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Neuronetics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 LivaNova PLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Baxter
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Polyganics BV
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations